Join the Juvenile Rheumatoid Arthritis group to help and get support from people like you.
Juvenile Rheumatoid Arthritis News
Related terms: Juvenile Chronic Polyarthritis, JRA
Rheumatic Diseases Have an Impact on Reproductive Health
WEDNESDAY, April 3, 2024 – Rheumatic diseases have a broad impact on reproductive success and pregnancy outcomes, according to a study published online March 20 in Rheumatology. Anne M. Kerola, ...
Sinusitis Linked to Increased Risk for Subsequent Rheumatic Disease
WEDNESDAY, Feb. 28, 2024 – A history of sinusitis is associated with an increased incidence of rheumatic disease, according to a study published online Feb. 27 in RMD Open. Vanessa L. Kronzer, M.D.,...
FDA Approves Tofidence (tocilizumab-bavi), a Biosimilar to Actemra
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) – Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved Tofidence (tocilizumab-bavi) intravenous...
Rheumatoid Arthritis Tied to Higher Risk for Aortic Stenosis
WEDNESDAY, Aug. 2, 2023 – Rheumatoid arthritis (RA) is associated with a higher risk for developing aortic stenosis, according to a study published online July 31 in JAMA Internal Medicine. Tate M....
Prevalence of Arthritis 305 Per 100,000 Children, Teens in U.S.
THURSDAY, July 20, 2023 – The prevalence of arthritis is 305 per 100,000 children and adolescents in the United States, with higher prevalence among non-Hispanic Black or African American versus...
Investigational Drug Peresolimab May Offer New Approach Against Rheumatoid Arthritis
THURSDAY, May 18, 2023 – An investigational drug may hit the reset button on a faulty immune system for some people with rheumatoid arthritis. Rheumatoid arthritis, or RA, is an autoimmune disease...
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA)
South San Francisco, CA – September 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the...
FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira
Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a p...
Otrexup (Methotrexate) Injection Approved By FDA
EWING, N.J., October 14, 2013 — Antares Pharma, Inc. today announced the approval of Otrexup (methotrexate) injection by the U.S. Food and Drug Administration (FDA). Otrexup is the first FDA approved ...
Ilaris Approved by FDA to Treat Active Systemic Juvenile Idiopathic Arthritis
Basel, May 10, 2013 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis...
FDA Approves Actemra for Children with Polyarticular Juvenile Idiopathic Arthritis
BASEL, April 30, 2013 – Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) for the treatment of polyarticular juvenile idiopathic arthritis...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Related drug support groups
prednisone, ibuprofen, meloxicam, aspirin, Celebrex, Advil, Motrin, Enbrel, Mobic, dexamethasone, Arthritis Pain, etanercept